Relapsing pediatric MOG Ab-associated disease: treatment response better characterized

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • In children with relapsing myelin oligodendrocyte glycoprotein antibody (MOG Ab) –associated disease, certain treatments reduce relapses and disability.

Why this matters

  • Treatment responsiveness of relapsing pediatric MOG Ab–associated disease is unclear.

Key resul...